We evaluated the effect of rapamycin alone and the potential synergism between AUY922 and rapamycin on induction of autophagy activation, KIT reduction and growth inhibition in IM-resistant, mutant KIT-expression GIST cells both in vitro and in vivo. Here, KIT is linked to gastrointestinal stromal tumor.